Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
Huntington's disease is caused by an abnormal polyglutamine expansion within the protein huntingtin and is characterized by microscopic inclusion bodies of aggregated huntingtin and by the death of selected types of neuron. Whether inclusion bodies are pathogenic, incidental or a beneficial coping response is controversial. To resolve this issue we have developed an automated microscope that returns to precisely the same neuron after arbitrary intervals, even after cells have been removed from the microscope stage. Here we show, by survival analysis, that neurons die in a time-independent fashion but one that is dependent on mutant huntingtin dose and polyglutamine expansion; many neurons die without forming an inclusion body. Rather, the amount of diffuse intracellular huntingtin predicts whether and when inclusion body formation or death will occur. Surprisingly, inclusion body formation predicts improved survival and leads to decreased levels of mutant huntingtin elsewhere in a neuron. Thus, inclusion body formation can function as a coping response to toxic mutant huntingtin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This conclusion is consistent with the view that soluble oligomers are the major proteotoxic species in neurodegenerative diseases and that their sequestration into insoluble aggregates reduces proteotoxicity (Arrasate et al., 2004; Cohen et al., 2006; Cohen et al., 2009).”
From Widespread Proteome Remodeling and Aggregation in Aging C. elegans (2015) · cites this paper as Arrasate et al., 2004
Citations
Cites
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674 · cited 1×
“The relationships between these factors were determined by survival analysis without introducing potentially confounding nonspecific manipulation”
BackgroundMangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073 · cited 1×
“and is sufficient to produce HD-like features when expressed as a transgene in a mous”
BackgroundAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
A monomeric red fluorescent protein
Campbell, R. E., Tour, O., Palmer, A. E., Steinbach, P. A., Baird, G. S., Zacharias, D. A., & Tsien, R. Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082243699 · Cited by 2,365 · cited 1×
“Along with Htt ex1 -GFP, neurons were co-transfected with a monomeric red fluorescent protein (mRFP”
MethodRavikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347 · cited 1×
“It remains unclear whether levels fall because of autophag”
BackgroundImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N. F., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,187
Davies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,595
Self-citationScherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenbach, B., Hasenbank, R., Bates, G. P., Davies, S. W., Lehrach, H., & Wanker, E. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80514-0 · Cited by 1,291
Modelling Survival Data in Medical Research
Collett, D. (1994) · Springer eBooks · doi:10.1007/978-1-4899-3115-3 · Cited by 1,065
Ataxin-1 Nuclear Localization and Aggregation
Klement, I. A., Skinner, P. J., Kaytor, M. D., Yi, H., Hersch, S. M., Clark, H. B., Zoghbi, H. Y., & Orr, H. T. (1998) · Cell · doi:10.1016/s0092-8674(00)81781-x · Cited by 956
CREB: A Major Mediator of Neuronal Neurotrophin Responses
Finkbeiner, S., Tavazoie, S. F., Maloratsky, A., Jacobs, K. M., Harris, K. M., & Greenberg, M. E. (1997) · Neuron · doi:10.1016/s0896-6273(00)80395-5 · Cited by 949
Self-citationNuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology
Gutekunst, C.-A., Li, S.-H., Yi, H., Mulroy, J. S., Kuemmerle, S., Jones, R., Rye, D., Ferrante, R. J., Hersch, S. M., & Li, X.-J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-07-02522.1999 · Cited by 914 · cited 1×
“IBs became detectable at less than 1 µm 2 and achieved sizes similar to those in H”
Differential loss of striatal projection neurons in Huntington disease.
Reiner, A., Albin, R. L., Anderson, K. D., D'Amato, C. J., Penney, J. B., & Young, A. B. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.15.5733 · Cited by 839 · cited 1×
“However, these cultures contain subtypes of striatal neuron whose susceptibility varies in H”
BackgroundTrehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease
Tanaka, M., Machida, Y., Niu, S., Ikeda, T., Jana, N. R., Doi, H., Kurosawa, M., Nekooki, M., & Nukina, N. (2004) · Nature Medicine · doi:10.1038/nm985 · Cited by 782 · cited 1×
“Our results support the hypothesis that manipulations that improve survival and decrease IB formation (for example, certain aggregation inhibitors) might do so by interfering with the formation of toxic diffuse Htt species or with their ability to act on critical intracellular cellular target”
ResultGoldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., Kazemi-Esfarjani, P., Thornberry, N. A., Vaillancourt, J. P., et al. (1996) · Nature Genetics · doi:10.1038/ng0896-442 · Cited by 581
Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9158 · Cited by 562
Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders
Sánchez, I., Mahlke, C., & Yuan, J. (2003) · Nature · doi:10.1038/nature01301 · Cited by 503 · cited 1×
“Our results support the hypothesis that manipulations that improve survival and decrease IB formation (for example, certain aggregation inhibitors) might do so by interfering with the formation of toxic diffuse Htt species or with their ability to act on critical intracellular cellular target”
ResultCummings, C. J., Reinstein, E., Sun, Y., Antalffy, B., Jiang, Y.-H., Ciechanover, A., Orr, H. T., Beaudet, A. L., & Zoghbi, H. Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)81035-1 · Cited by 501
Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D., & Housman, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11404 · Cited by 443
Becher, M. W., Kotzuk, J. A., Sharp, A. H., Davies, S. W., Bates, G. P., Price, D. L., & Ross, C. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0168 · Cited by 433
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
Taylor, J. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg074 · Cited by 426
Kim, Y. J., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K. B., Qin, Z.-H., Aronin, N., & DiFiglia, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221451398 · Cited by 398
Ross, C. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80405-5 · Cited by 388
Ordway, J. M., Tallaksen-Greene, S., Gutekunst, C.-A., Bernstein, E. M., Cearley, J. A., Wiener, H. W., Dure, L. S., Lindsey, R., Hersch, S. M., Jope, R. S., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80464-x · Cited by 370
Huntingtin Spheroids and Protofibrils as Precursors in Polyglutamine Fibrilization
Poirier, M. A., Li, H., Macosko, J., Cai, S., Amzel, M., & Ross, C. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205809200 · Cited by 367 · cited 1×
“IBs seem to result from aggregation that generates many protein complexes differing in multimerization and three-dimensional structur”
BackgroundWyttenbach, A., Carmichael, J., Swartz, J., Furlong, R. A., Narain, Y., Rankin, J., & Rubinsztein, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.6.2898 · Cited by 363 · cited 1×
“Attempts to disrupt the aggregation process yielded opposing results, depending on the manipulatio”
ResultHuntington aggregates may not predict neuronal death in Huntington's disease.
Kuemmerle, S., Gutekunst, C., Klein, A., Li, X. J., Li, S. H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) · PubMed · Cited by 362
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity
Chen, S., Berthelier, V., Yang, W., & Wetzel, R. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4850 · Cited by 334
Huntingtin aggregates may not predict neuronal death in Huntington's disease
Kuemmerle, S., Gutekunst, C.-A., Klein, A. M., Li, X.-J., Li, S.-H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199912)46:6<842::aid-ana6>3.0.co;2-o · Cited by 308 · cited 1×
“Is IB formation even necessary for polyQ-expansion-dependent death? IB formation has been dissociated from polyQ-dependent deat”
BackgroundKim, M., Lee, H.-S., LaForet, G., McIntyre, C., Martin, E. J., Chang, P., Kim, T. W., Williams, M., Reddy, P. H., Tagle, D., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-03-00964.1999 · Cited by 305
A one-hit model of cell death in inherited neuronal degenerations
Clarke, G., Collins, R. A., Leavitt, B. R., Andrews, D. F., Hayden, M. R., Lumsden, C. J., & McInnes, R. R. (2000) · Nature · doi:10.1038/35018098 · Cited by 303 · cited 1×
“Knowing whether the risk of death changes over time can provide insights into the mechanisms responsible for neurodegeneratio”
BackgroundKegel, K. B., Meloni, A. R., Yi, Y., Kim, Y. J., Doyle, E., Cuiffo, B. G., Sapp, E., Wang, Y., Qin, Z.-H., Chen, J. D., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m103946200 · Cited by 287 · cited 1×
“The nucleus seems to be an important site of toxicity for mutant Ht”
BackgroundNuclear Inclusions in Glutamine Repeat Disorders
Sisodia, S. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81743-2 · Cited by 259
Specificity in intracellular protein aggregation and inclusion body formation
Rajan, R. S., Illing, M. E., Bence, N. F., & Kopito, R. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181479798 · Cited by 237
Yoo, S.-Y., Pennesi, M. E., Weeber, E. J., Xu, B., Atkinson, R., Chen, S., Armstrong, D. L., Wu, S. M., Sweatt, J. D., & Zoghbi, H. Y. (2003) · Neuron · doi:10.1016/s0896-6273(02)01190-x · Cited by 233 · cited 1×
“PolyQ expansions in ataxin-7 might cause toxicity by stabilizing ataxin-7, causing soluble forms to accumulat”
BackgroundCause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats
Perutz, M. F., & Windle, A. H. (2001) · Nature · doi:10.1038/35084141 · Cited by 199
Nuclear Targeting of Mutant Huntingtin Increases Toxicity
Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.1999.0773 · Cited by 191 · cited 1×
“The nucleus seems to be an important site of toxicity for mutant Ht”
BackgroundApostol, B. L., Kazantsev, A., Raffioni, S., Illes, K., Pallos, J., Bodai, L., Slepko, N., Bear, J. E., Gertler, F. B., Hersch, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2628045100 · Cited by 173
Mende-Mueller, L. M., Toneff, T., Hwang, S.-R., Chesselet, M.-F., & Hook, V. Y. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01830.2001 · Cited by 163
Richfield, E. K., Maguire‐Zeiss, K. A., Vonkeman, H. E., & Voorn, P. (1995) · Annals of Neurology · doi:10.1002/ana.410380605 · Cited by 153 · cited 1×
“However, these cultures contain subtypes of striatal neuron whose susceptibility varies in H”
BackgroundA cell-based screen for drugs to treat Huntington's disease
Aiken, C. T., Tobin, A. J., & Schweitzer, E. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.001 · Cited by 135 · cited 1×
“PC12 cells inducibly expressing Htt ex1 -Q 25 -GFP or Htt ex1 -Q 103 -GF”
BackgroundSelf-citationMuchowski, P. J., Ning, K., D'Souza-Schorey, C., & Fields, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022628699 · Cited by 132 · cited 1×
“Attempts to disrupt the aggregation process yielded opposing results, depending on the manipulatio”
ResultModelling Survival Data in Medical Research. By D. Collett (Chapman & Hall, 1994) £19.99
Macdonald, A. S. (1995) · British Actuarial Journal · doi:10.1017/s1357321700001173 · Cited by 122
Moulder, K. L., Onodera, O., Burke, J. R., Strittmatter, W. J., & Johnson, E. M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00705.1999 · Cited by 94
Evidence for a recruitment and sequestration mechanism in Huntington'sdisease
Preisinger, E., Jordan, B. M., Kazantsev, A., & Housman, D. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0455 · Cited by 93
Differential Expression of Normal and Mutant Huntington's Disease Gene Alleles
Persichetti, F., Carlée, L., Faber, P. W., McNeil, S. M., Ambrose, C. M., Srinidhi, J., Anderson, M., Barnes, G. T., Gusella, J. F., & MacDonald, M. E. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0018 · Cited by 82
Green fluorescent protein as a novel tool to measure apoptosis and necrosis
Strebel, A., Harr, T., Bachmann, F., Wernli, M., & Erb, P. (2001) · Cytometry · Cited by 71
Expanded polyglutamine stretches form an ‘aggresome’
Shimohata, T., Sato, A., Burke, J. R., Strittmatter, W. J., Tsuji, S., & Onodera, O. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00162-3 · Cited by 40
Green fluorescent protein as a quantitative tool
Hack, N., Billups, B., Guthrie, P. B., ROGERS, J. H., Muir, E. M., Parks, T. N., & Kater, S. B. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(99)00178-8 · Cited by 30 · cited 1×
“To determine whether GFP fluorescence can be used to quantify levels of GFP-tagged protein in single cell”
BackgroundMolecular Genetics of Huntington’s Disease
MacDonald, M. E. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69680-3_2 · Cited by 14
Trinucleotide Diseases and Instability
Oostra, B. A. (1998) · Results and problems in cell differentiation · doi:10.1007/978-3-540-69680-3 · Cited by 10
A one-hit model of cell death in inherited neuronal degenerations
Bortolotto, Z. A., Clarke, V. R. J., Delany, C. M., Parry, M., Smolders, I. J., Vignes, M., Ho, K. H., Miu, P., Brinton, B. T., Fantaske, R. P., et al. (2001) · Cited by 9
Research works printed but not linked: 1
- Arrasate, M., Brooks, L., Chang, P., Mitra, S. & Finkbeiner, S. Longitudinal analysis to identify pathogenic factors in a striatal model of Huntington's disease. Soc. Neurosci. Abstr. 29, 209.8 (2003)
Cited by
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744
“For example, in cell-culture studies of HD, less cell death has been observed when large aggregates of polyglutamine-rich huntingtin protein are present in the cells than when only soluble huntingtin is present without these inclusion”
BackgroundSuppression of basal autophagy in neural cells causes neurodegenerative disease in mice
Hara, T., Nakamura, K., Matsui, M., Yamamoto, A., Nakahara, Y., Suzuki-Migishima, R., Yokoyama, M., Mishima, K., Saito, I., Okano, H., et al. (2006) · Nature · doi:10.1038/nature04724 · Cited by 3,882
Bjørkøy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Øvervatn, A., Stenmark, H., & Johansen, T. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200507002 · Cited by 3,276
“We suggest that p62 may, via LC3, be involved in linking polyubiquitinated protein aggregates to the autophagy machinery.”
Neurodegenerative Disorders: Parkinson's Disease and Huntington's Disease
Hague, S., Klaffke, S., & Bandmann, O. (2006) · IMPERIAL COLLEGE PRESS eBooks · doi:10.1142/9781860948961_0007 · Cited by 2,767
Metadata
- Authors
- Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., & Finkbeiner, S.
- Affiliations
- University of California, San Francisco (US)
- University of California, Los Angeles (US)
- Corresponding author
- Finkbeiner, Steven
- Venue
- Nature
- Published
- 2004-10
- Volume
- 431
- Issue
- 7010
- Pages
- 805-810
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2106200048
- Cited by
- 1,979
- References
- 53
- Citations by year
- 2026: 20 · 2025: 40 · 2024: 50 · 2023: 58 · 2022: 79 · 2021: 64 · 2020: 69 · 2019: 73 · 2018: 78 · 2017: 88 · 2016: 98 · 2015: 87 · 2014: 103 · 2013: 111 · 2012: 123
- FWCI
- 46.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Larry L. Hillblom Foundation
- Hereditary Disease Foundation
- Cure Huntington's Disease Initiative
- Gladstone Institutes
- Ministerio de Educación, Cultura y Deporte
- National Institutes of Health
- University of California, San Francisco
- National Institute of General Medical Sciences
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Huntington's disease, mutant huntingtin, polyglutamine expansion, inclusion bodies, neuronal cell death, neuroprotection, survival analysis, automated microscope, dose-dependent toxicity
- MeSH terms
- Huntingtin Protein, Animals, Cell Line, Cell Survival, Cells, Cultured, Inclusion Bodies, Humans, Huntington Disease, Models, Biological, Mutation, Nerve Tissue Proteins, Neurons, Nuclear Proteins, Peptides, Cell Death, Neostriatum, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.